Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer.

PLoS One · 2013 · PMC3665805 · PMID 23724098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

This observation may be significant since, if it is true, it could affect how patients are selected in the clinical trials investigating new targeting agents for the KRAS pathway as well as how patients are treated in clinical practice.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.